ALLIX HODGES: Open Payments
NPI 1992323224 · WHITNEY POINT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 21 payments from 8 companies in 2025. Trend: 2023 $408 · 2024 $234 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $191 |
| Novo Nordisk Inc | 6 | $164 |
| PFIZER INC. | 4 | $62 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Lilly USA, LLC | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
Products named: BREZTRI, Ozempic, AIRSUPRA, MOUNJARO, PREVNAR 20, ELIQUIS, TRELEGY ELLIPTA, Rybelsus.
Industry payments across NY — which companies pay providers there.
